Guilherme Dias Melo et al.
Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
EMBO Molecular Medicine 2021
doi: 10.15252/emmm.202114122
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Guilherme Dias Melo et al.
Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
EMBO Molecular Medicine 2021
doi: 10.15252/emmm.202114122